Biotech

All Articles

ProKidney stops phase 3 trial not required for tissue therapy approval

.ProKidney has actually quit among a set of phase 3 tests for its tissue therapy for kidney disease ...

Vaxcyte climbs on 'spectacular' 31-valent PCV succeed against Pfizer

.Vaxcyte introduced what professionals called "impressive" stage 1/2 information for its 31-valent p...

Recursion's human brain ailment test presents little proof of effectiveness

.Recursion has discovered through an early test of its own tech-enabled technique to drug revelation...

Acepodia, Pfizer click on all together for chemistry-based tissue therapy

.Contact it a scenario of good chemistry: Acepodia, a biotech based upon Nobel Prize-winning scienti...

Praxis epilepsy medication lowers seizures in phase 2 trial

.Praxis Precision Medicines has scored an additional midphase win in epilepsy this year, with its sa...

Three officers resign as Dyne messages blended information for DMD prospect

.After getting away a medical grip many years back, Dyne Therapy has revealed brand-new stage 1/2 in...

Arrowhead fires off period 3 data in uncommon metabolic disease in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its own give before a potential face-off with Ioni...

Pfizer, Valneva reveal lyme illness go reliable for second booster

.Pfizer and also Valneva might have regarding pair of additional years to hang around before they pr...

Fierce Biotech Managing Editor Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Allow's dive into a talk along with Ayla Ellison, Fierce Biotech Editor-in-Chief and also Michelle ...

New records show how Bayer's asundexian failed to avoid strokes

.Bayer put on hold the stage 3 trial for its own factor XIa inhibitor asundexian behind time in 2015...